{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:31:43Z","timestamp":1783607503848,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1007\/s11864-004-0022-6","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T08:46:16Z","timestamp":1183020376000},"page":"315-325","source":"Crossref","is-referenced-by-count":57,"title":["Multiple endocrine neoplasia type 2"],"prefix":"10.1007","volume":"5","author":[{"given":"Michael E.","family":"Gertner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electron","family":"Kebebew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jc.86.12.5658","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A, et al.: Guidelines for diagnosis and therapy of MEN type 1 and type 2?\n                           J Clin Endocrinol Metab 2001, 86:5658\u20135671.","journal-title":"J Clin Endocrinol Metab"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/jama.276.19.1575","volume":"276","author":"C Eng","year":"1996","unstructured":"Eng C, Clayton D, Schuffenecker I, et al.: The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis?\n                           JAMA 1996, 276:1575\u20131579. This paper provides useful data of genotype-phenotype correlations in a large MEN-2 study cohort.","journal-title":"JAMA"},{"key":"22_CR3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2265.1989.tb03727.x","volume":"30","author":"V Nunziata","year":"1989","unstructured":"Nunziata V, Giannattasio R, Di Giovanni G, et al.: Hereditary localized pruritus in affected members of a kindred with multiple endocrine neoplasia type 2A (Sipple\u2019s syndrome)?\n                           Clin Endocrinol (Oxf) 1989, 30:57\u201363.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/00005176-198212000-00027","volume":"1","author":"M Verdy","year":"1982","unstructured":"Verdy M, Weber AM, Roy CC, et al.: Hirschsprung\u2019s disease in a family with multiple endocrine neoplasia type 2?\n                           J Pediatr Gastroenterol Nutr 1982, 1:603\u2013607.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJM198802253180804","volume":"318","author":"RF Gagel","year":"1988","unstructured":"Gagel RF, Tashjian AH Jr, Cummings T, et al.: The clinical outcome of prospective screening for multiple endo-crine neoplasia type 2a: an 18-year experience?\n                           N Engl J Med 1988, 318:478\u2013484.","journal-title":"N Engl J Med"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","volume":"88","author":"E Kebebew","year":"2000","unstructured":"Kebebew E, Ituarte PH, Siperstein AE, et al.: Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging sys-tems?\n                           Cancer 2000, 88:1139\u20131148.","journal-title":"Cancer"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jc.86.12.5658","volume":"86","author":"M Brandi","year":"2001","unstructured":"Brandi M, Gagel R, Angeli A, Bilezikian J: Guidelines for diagnosis and therapy of MEN type 1 and type 2?\n                           J Clin Endocrinol Metab 2001, 86:5658\u20135671.","journal-title":"J Clin Endocrinol Metab"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00000658-199409000-00002","volume":"220","author":"SA Wells","year":"1994","unstructured":"Wells SA Jr, Chi DD, Toshima K, et al.: Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A?\n                           Ann Surg 1994, 220:237\u2013247. One of the first studies to document the use of prophylactic total thyroidectomy in RET germline mutation carriers and the pathologic findings, in addition to the biochemical cure of patients diagnosed by screening for RET germline mutations.","journal-title":"Ann Surg"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s002689900463","volume":"22","author":"H Dralle","year":"1998","unstructured":"Dralle H, Gimm O, Simon D, et al.: Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience?\n                           World J Surg 1998, 22:744\u2013750.","journal-title":"World J Surg"},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa012915","volume":"349","author":"A Machens","year":"2003","unstructured":"Machens A, Niccoli-Sire P, Hoegel J, et al.: Early malignant progression of hereditary medullary thyroid cancer?\n                           N Engl J Med 2003, 349:1517\u20131525. A large cohort study of patients with MEN-2 that provides useful data on the clinical progression of MTC and the earliest age MTC may occur given a specific codon mutation.","journal-title":"N Engl J Med"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0065-230X(08)60875-1","volume":"70","author":"BA Ponder","year":"1996","unstructured":"Ponder BA, Smith D: The MEN II syndromes and the role of the RET proto-oncogene?\n                           Adv Cancer Res 1996, 70:179\u2013222.","journal-title":"Adv Cancer Res"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/gcc.2870120308","volume":"12","author":"C Eng","year":"1995","unstructured":"Eng C, Mulligan LM, Smith DP, et al.: Mutation of the RET proto-oncogene in sporadic medullary thyroid carcinoma?\n                           Genes Chromosomes Cancer 1995, 12:209\u2013212.","journal-title":"Genes Chromosomes Cancer"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/00000658-199906000-00016","volume":"229","author":"JF Moley","year":"1999","unstructured":"Moley JF, DeBenedetti MK: Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection?\n                           Ann Surg 1999, 229:880\u2013887.","journal-title":"Ann Surg"},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/cncr.11581","volume":"98","author":"A Machens","year":"2003","unstructured":"Machens A, Holzhausen HJ, Lautenschlager C, et al.: Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma?\n                           Cancer 2003, 98:712\u2013719.","journal-title":"Cancer"},{"key":"22_CR15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/thy.1999.9.127","volume":"9","author":"E Kebebew","year":"1999","unstructured":"Kebebew E, Tresler PA, Siperstein AE, et al.: Normal thyroid pathology in patients undergoing thyroidectomy for finding a RET gene germline mutation: a report of three cases and review of the literature?\n                           Thyroid 1999, 9:127\u2013131.","journal-title":"Thyroid"},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/archsurg.138.4.409","volume":"138","author":"L Yip","year":"2003","unstructured":"Yip L, Cote GJ, Shapiro SE, et al.: Multiple endocrine neoplasia type 2: evaluation of the genotype-pheno-type relationship?\n                           Arch Surg 2003, 138:409\u2013416. This paper provides useful RET genotype-phenotype data in patients with MEN-2 and the risk stratification of patients according to the affected RET codon.","journal-title":"Arch Surg"},{"key":"22_CR17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00000658-199806000-00012","volume":"227","author":"H Chen","year":"1998","unstructured":"Chen H, Roberts JR, Ball DW, et al.: Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection?\n                           Ann Surg 1998, 227:887\u2013895.","journal-title":"Ann Surg"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/archsurg.135.8.895","volume":"135","author":"E Kebebew","year":"2000","unstructured":"Kebebew E, Kikuchi S, Duh QY, Clark OH: Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer?\n                           Arch Surg 2000, 135:895\u2013901.","journal-title":"Arch Surg"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1097\/00000658-199010000-00002","volume":"212","author":"JA van Heerden","year":"1990","unstructured":"van Heerden JA, Grant CS, Gharib H, et al.: Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma?\n                           Ann Surg 1990, 212:3950\u2013400.","journal-title":"Ann Surg"},{"key":"22_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00268-003-6903-1","volume":"28","author":"L Rosato","year":"2004","unstructured":"Rosato L, Avenia N, Bernante P, et al.: Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years?\n                           World J Surg 2004, 28:271\u2013276.","journal-title":"World J Surg"},{"key":"22_CR21","first-page":"1","volume":"183","author":"LM Brunt","year":"1996","unstructured":"Brunt LM, Doherty GM, Norton JA, et al.: Laparoscopic adrenalectomy compared to open adrenalectomy for benign adrenal neoplasms?\n                           J Am Coll Surg 1996, 183:1\u201310.","journal-title":"J Am Coll Surg"},{"key":"22_CR22","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s00268-002-6669-x","volume":"26","author":"WK Cheah","year":"2002","unstructured":"Cheah WK, Clark OH, Horn JK, et al.: Laparoscopic adrenalectomy for pheochromocytoma?\n                           World J Surg 2002, 26:1048\u20131051.","journal-title":"World J Surg"},{"key":"22_CR23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archsurg.1995.01430050039006","volume":"130","author":"RA Prinz","year":"1995","unstructured":"Prinz RA: A comparison of laparoscopic and open adrenalectomies?\n                           Arch Surg 1995, 130:489\u2013492.","journal-title":"Arch Surg"},{"key":"22_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/00000658-199306000-00001","volume":"217","author":"TC Lairmore","year":"1993","unstructured":"Lairmore TC, Ball DW, Baylin SB, Wells SA Jr: Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes?\n                           Ann Surg 1993, 217: 595\u2013601.","journal-title":"Ann Surg"},{"key":"22_CR25","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archsurg.1996.01430200080014","volume":"131","author":"QY Duh","year":"1996","unstructured":"Duh QY, Siperstein AE, Clark OH, et al.: Laparoscopic adrenalectomy: comparison of the lateral and posterior approaches?\n                           Arch Surg 1996, 131:870\u2013875.","journal-title":"Arch Surg"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.surg.2003.07.027","volume":"134","author":"M Iihara","year":"2003","unstructured":"Iihara M, Suzuki R, Kawamata A, et al.: Adrenal-preserv-ing laparoscopic surgery in selected patients with bilateral adrenal tumors?\n                           Surgery 2003, 134:1066\u20131072.","journal-title":"Surgery"},{"key":"22_CR27","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S0039-6060(96)80056-0","volume":"120","author":"JE Lee","year":"1996","unstructured":"Lee JE, Curley SA, Gagel RF, et al.: Cortical-sparing adrenalectomy for patients with bilateral pheochro-mocytoma?\n                           Surgery 1996, 120:1064\u20131070.","journal-title":"Surgery"},{"key":"22_CR28","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/jc.83.2.487","volume":"83","author":"I Schuffenecker","year":"1998","unstructured":"Schuffenecker I, Virally-Monod M, Brohet R, et al.: Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D\u2019etude des Tumeurs a Calcitonine?\n                           J Clin Endocrinol Metab 1998, 83:487\u2013491.","journal-title":"J Clin Endocrinol Metab"},{"key":"22_CR29","first-page":"1031","volume":"114","author":"DS O\u2019Riordain","year":"1993","unstructured":"O\u2019Riordain DS, O\u2019Brien T, Grant CS, et al.: Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2?\n                           Surgery 1993, 114: 1031\u20131037.","journal-title":"Surgery"},{"key":"22_CR30","first-page":"1080","volume":"112","author":"JL Kraimps","year":"1992","unstructured":"Kraimps JL, Duh QY, Demeure M, Clark OH: Hyperparathyroidism in multiple endocrine neoplasia syndrome?\n                           Surgery 1992, 112: 1080\u20131086.","journal-title":"Surgery"},{"key":"22_CR31","first-page":"157","volume":"8","author":"BD Nelkin","year":"2001","unstructured":"Nelkin BD, Ball DW: Combretastatin A-4 and doxorubicin combination treatment is effective in a preclinical model of human medullary thyroid carcinoma?\n                           Oncol Rep 2001, 8:157\u2013160.","journal-title":"Oncol Rep"},{"key":"22_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.surg.2003.11.003","volume":"135","author":"Menacho I Plaza","year":"2004","unstructured":"Plaza Menacho I, de Groot JW, Links T, et al.: Inhibition of medullary thyroid carcinoma (MTC) cell prolifera-tion and RET phosphorylation by tyrosine kinase inhibitors?\n                           Surgery 2004, 135:240\u2013241.","journal-title":"Surgery"},{"key":"22_CR33","first-page":"3601","volume":"23","author":"MA Skinner","year":"2003","unstructured":"Skinner MA, Safford SD, Freemerman AJ: RET tyrosine kinase and medullary thyroid cells are unaffected by clinical doses of STI571?\n                           Anticancer Res 2003, 23:3601\u20133606.","journal-title":"Anticancer Res"},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1067\/msy.2002.128562","volume":"132","author":"MS Cohen","year":"2002","unstructured":"Cohen MS, Hussain HB, Moley JF: Inhibition of medullary thyroid carcinoma cell proliferation and RET phosphorylation by tyrosine kinase inhibitors?\n                           Surgery 2002, 132:960\u2013966.","journal-title":"Surgery"},{"key":"22_CR35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/thy.1996.6.305","volume":"6","author":"J Brierley","year":"1996","unstructured":"Brierley J, Tsang R, Simpson WJ, et al.: Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control?\n                           Thyroid 1996, 6:305\u2013310.","journal-title":"Thyroid"},{"key":"22_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0889-8529(05)70316-9","volume":"25","author":"JD Brierley","year":"1996","unstructured":"Brierley JD, Tsang RW: External radiation therapy in the treatment of thyroid malignancy?\n                           Endocrinol Metab Clin North Am 1996, 25:141\u2013157.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"22_CR37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1210\/jcem-67-4-801","volume":"67","author":"NA Samaan","year":"1988","unstructured":"Samaan NA, Schultz PN, Hickey RC: Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy?\n                           J Clin Endocrinol Metab 1988, 67:801\u2013805.","journal-title":"J Clin Endocrinol Metab"},{"key":"22_CR38","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0748-7983(96)92294-5","volume":"22","author":"KM Fife","year":"1996","unstructured":"Fife KM, Bower M, Harmer CL: Medullary thyroid cancer: the role of radiotherapy in local control?\n                           Eur J Surg Oncol 1996, 22:588\u2013591.","journal-title":"Eur J Surg Oncol"},{"key":"22_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0167-8140(92)90298-9","volume":"23","author":"TD Nguyen","year":"1992","unstructured":"Nguyen TD, Chassard JL, Lagarde P, et al.: Results of postoperative radiation therapy in medullary carcinoma of the thyroid: a retrospective study by the French Federation of Cancer Institutes-the Radiotherapy Cooperative Group?\n                           Radiother Oncol 1992, 23:1\u20135.","journal-title":"Radiother Oncol"},{"key":"22_CR40","first-page":"93","volume":"41","author":"ME Juweid","year":"2000","unstructured":"Juweid ME, Hajjar G, Stein R, et al.: Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR?\n                           J Nucl Med 2000, 41: 93\u2013103.","journal-title":"J Nucl Med"},{"key":"22_CR41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF03345807","volume":"15","author":"M Schlumberger","year":"1992","unstructured":"Schlumberger M, Gicquel C, Lumbroso J, et al.: Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases?\n                           J Endocrinol Invest 1992, 15:631\u2013642.","journal-title":"J Endocrinol Invest"},{"key":"22_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/cncr.11518","volume":"98","author":"B Rose","year":"2003","unstructured":"Rose B, Matthay KK, Price D, et al.: High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma?\n                           Cancer 2003, 98:239\u2013248.","journal-title":"Cancer"},{"key":"22_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0960-7404(00)00038-4","volume":"9","author":"N Lee","year":"2000","unstructured":"Lee N, Norton J: Multiple endocrine neoplasia type 2B: genetic basis and clinical expression?\n                           Surg Oncol 2000, 9:111\u2013118.","journal-title":"Surg Oncol"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-004-0022-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-004-0022-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-004-0022-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-004-0022-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T13:18:05Z","timestamp":1652620685000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-004-0022-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s11864-004-0022-6","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}